Drug General Information
Drug ID	D05RTM
Former ID	DNCL002877
Drug Name	LEZ763
Indication	Peripheral arterial disease; Type 2 diabetes [ICD9: 443, 250; ICD10:I73, E11]		Phase 1/2	[523944]
Company	Novartis
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Glucose-dependent insulinotropic receptor	Target Info	Modulator
KEGG Pathway	cAMP signaling pathway
	Insulin secretion
WikiPathways	Incretin Synthesis, Secretion, and Inactivation
References
Ref 523944	ClinicalTrials.gov (NCT01619332) Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.